|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Washington University, St Louis, MO, USA
* To whom correspondence should be addressed. E-mail: morrison{at}pcg.wustl.edu.
Several related isoforms of p38MAPK have been identified and cloned in many species. While they all contain the dual phosphorylation motif TGY, the expression of these isoforms is not ubiquitous. p38
and
2 are ubiquitously expressed while p38
and
appear to have more restricted expression. Since there is evidence for selective activation by upstream kinases and selective preference for downstream substrates, the functions of these conserved proteins is still incompletely understood. We have demonstrated that the renal mesangial cell expresses the mRNA for all the isoforms of p38MAPK, with p38
mRNA expressed at the highest level, followed by p38
and the lowest levels of expression by p38
2 and
. To determine the functional effects of these proteins on IL-1
-induced iNOS expression, we transduced TAT-p38 chimeric proteins into renal mesangial cells and assessed the effects of wild type and mutant p38 isoforms on ligand induced iNOS expression. We show that while p38
and
had minimal effects on iNOS expression, p38
and
2 do. p38
mutant and p38
2 wild type dose dependently inhibited IL-1
-induced iNOS expression. This data suggests that p38
and
2 have reciprocal effects on iNOS expression in the mesangial cell and these observations may have important consequences for the development of selective inhibitors targeting the p38MAPK family of proteins.
This article has been cited by other articles:
![]() |
M. J. Kelley, A. Rose, K. Song, B. Lystrup, J. W. Samples, and T. S. Acott p38 MAP Kinase Pathway and Stromelysin Regulation in Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3126 - 3137. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |